Literature DB >> 10188908

Prognostic role of p27Kip1 and apoptosis in human breast cancer.

J Wu1, Z Z Shen, J S Lu, M Jiang, Q X Han, J A Fontana, S H Barsky, Z M Shao.   

Abstract

Human breast carcinoma is biologically heterogeneous, and its clinical course may vary from an indolent slowly progressive one to a course associated with rapid progression and metastatic spread. It is important to establish prognostic factors which will define subgroups of patients with low vs high risk of recurrence so as to better define the need for additional therapy. Additional characterization of the molecular make-up of breast cancer phenotypes should provide important insights into the biology of breast cancer. In the present study, we investigated apoptosis, expression of p27Kip1 and p53 retrospectively in 181 human breast cancer specimens. In addition, their relevance to the biological behaviour of breast cancer was examined. Our studies found a significant association among high histological grade, high p53, low apoptosis and low p27. Our results also demonstrated that, in human breast cancer, low levels of p27 and apoptotic index (AI) strongly correlated with the presence of lymph node metastasis and decreased patient survival. In node-negative patients, however, p27 also had prognostic value for relapse-free and overall survival in multivariate analysis. Furthermore p27 and AI had predictive value for the benefits of chemotherapy. These latter observations should prompt prospective randomized studies designed to investigate the predictive role of p27 and AI in determining who should receive chemotherapy in node-negative patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188908      PMCID: PMC2362719          DOI: 10.1038/sj.bjc.6690250

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.

Authors:  J Gray-Bablin; S Rao; K Keyomarsi
Journal:  Cancer Res       Date:  1997-02-15       Impact factor: 12.701

Review 2.  Prognostic and response markers in the management of breast cancer.

Authors:  J Robertson
Journal:  Cancer Treat Rev       Date:  1997-07       Impact factor: 12.111

Review 3.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

4.  Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients.

Authors:  P L Porter; K E Malone; P J Heagerty; G M Alexander; L A Gatti; E J Firpo; J R Daling; J M Roberts
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

5.  Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.

Authors:  C Catzavelos; N Bhattacharya; Y C Ung; J A Wilson; L Roncari; C Sandhu; P Shaw; H Yeger; I Morava-Protzner; L Kapusta; E Franssen; K I Pritchard; J M Slingerland
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

6.  Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products.

Authors:  N E Langlois; J Lamb; O Eremin; S D Heys
Journal:  J Pathol       Date:  1997-08       Impact factor: 7.996

7.  The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.

Authors:  P Tan; B Cady; M Wanner; P Worland; B Cukor; C Magi-Galluzzi; P Lavin; G Draetta; M Pagano; M Loda
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

Review 8.  Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation.

Authors:  A Alessandrini; D S Chiaur; M Pagano
Journal:  Leukemia       Date:  1997-03       Impact factor: 11.528

9.  p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis.

Authors:  M Jiang; Z M Shao; J Wu; J S Lu; L M Yu; J D Yuan; Q X Han; Z Z Shen; J A Fontana
Journal:  Int J Cancer       Date:  1997-10-21       Impact factor: 7.396

10.  Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.

Authors:  V Esposito; A Baldi; A De Luca; A M Groger; M Loda; G G Giordano; M Caputi; F Baldi; M Pagano; A Giordano
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

View more
  12 in total

1.  Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression.

Authors:  X Zhang; Q Xu; I Saiki
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 2.  p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.

Authors:  Seth A Wander; Dekuang Zhao; Joyce M Slingerland
Journal:  Clin Cancer Res       Date:  2010-10-21       Impact factor: 12.531

3.  Molecular analysis of the p27/kip1 gene in breast cancer.

Authors:  Hatice Tigli; Nur Buyru; Nejat Dalay
Journal:  Mol Diagn       Date:  2005

Review 4.  p27 deregulation in breast cancer: prognostic significance and implications for therapy.

Authors:  A Alkarain; R Jordan; J Slingerland
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

5.  Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.

Authors:  Nicholas F S Watson; Lindy G Durrant; John H Scholefield; Zahra Madjd; Duncan Scrimgeour; Ian Spendlove; Ian O Ellis; Poulam M Patel
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

6.  MicroRNA-182-5p targets a network of genes involved in DNA repair.

Authors:  Keerthana Krishnan; Anita L Steptoe; Hilary C Martin; Shivangi Wani; Katia Nones; Nic Waddell; Mythily Mariasegaram; Peter T Simpson; Sunil R Lakhani; Brian Gabrielli; Alexander Vlassov; Nicole Cloonan; Sean M Grimmond
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

7.  Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.

Authors:  Valdi Pesutić-Pisac; Ante Punda; Ivo Gluncić; Vladimir Bedeković; Anka Pranić-Kragić; Nenad Kunac
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

Review 8.  Biomolecular features of clinical relevance in breast cancer.

Authors:  Maria Grazia Daidone; Angelo Paradiso; Massimo Gion; Nadia Harbeck; Fred Sweep; Manfred Schmitt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-17       Impact factor: 9.236

Review 9.  The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.

Authors:  R Chiarle; M Pagano; G Inghirami
Journal:  Breast Cancer Res       Date:  2000-12-20       Impact factor: 6.466

Review 10.  Prognostic molecular markers in early breast cancer.

Authors:  Francisco J Esteva; Gabriel N Hortobagyi
Journal:  Breast Cancer Res       Date:  2004-03-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.